Dr. Anke Caßing

Principal / Authorized Signatory

Dr. Anke Caßing

Principal / Authorized Signatory

Dr. Anke Caßing has many years of experience in strategic marketing and business development in medical technology, biotechnology and in pharmaceutics. She holds a doctorate in biology and studied economics. Before joining the HTGF, she developed the product portfolios of international companies ensuring their future growth.

Contact

Telefon:
+49 – (0)228 – 82300 – 148

Portfolio

Posts & mentions

26. April 2021

PreComb Therapeutics AG secures CHF 2.2 Mio seed financing to advance personalized medicine for cancer patients

PreComb develops the next generation point-of-care technology for patient-specific profiling of cancer therapies PreComb Therapeutics today announced the successful completion of the seed financing round led by Kinled Austria, the High-Tech Gründerfonds and FiveT capital, in addition to participations from other investors. Patrick Aisher, managing partner at Kinled Austria, joined the company’s board of directors. The seed funding will help advance the proprietary 3D3 Technol
 
17. February 2021

Angiolutions’ novel vascular implant defuses the abdominal ticking time bomb

The award-winning team of the medtech startup Angiolutions successfully secured its seed financing round with High-Tech Gründerfonds, FRIBA Investment and NBank Capital. Based on the founders’ research, the company aims to prevent the deadly progression of small abdominal aortic aneurysms. We are thrilled to work with a strong investor syndicate enabling the successful completion of our critical R&D steps.Dr. Uwe Raaz and Dr. Isabel N. Schellinger, founders of Angiolutions
 
3. December 2020

Lymphatica Medtech raises seven-digit Series A round

LYMPHATICA Medtech, a vascular medical device development start-up, closes a seven-digit financing round to advance clinical validation aiming at revolutionizing the treatment of chronic lymphoedema. The investment round, led by High-Tech Gründerfonds, was joined by business angels, the EIT health (European Institute of Innovation and Technology) and existing investors, including LIVEventures. The Company also announces the appointment of Laurent Duhoux (ex VP New Technology at Edwards L
 
25. November 2020

Emergence Therapeutics Announces a Bumped-up Follow-on Seed Round Financing

Financing enables company to embark on additional targets and expand ADC technology reach Emergence Therapeutics AG, a European biopharmaceutical company developing novel antibody drug conjugate (ADC) immuno-therapeutics to treat high need cancers, announces that is has closed a Bumped-up Follow-on Seed Round Financing from a syndicate of leading European investors comprising Bpifrance through its InnoBio 2 fund, Gründerfonds Ruhr, Heidelberg Pharma Research GmbH, High-Tech Gründerf
 
4. August 2020

High-tech firm from Singen, Germany, alongside HTGF (High-Tech Gründerfonds) and MBG co-invest: stimOS GmbH wins WEFA as strategic partner

WEFA Inotec GmbH (WEFA) – a German market leader in extrusion tooling, precision technology and CVD coatings - became a Series A investor in stimOS GmbH (stimOS), a South-Germany-based medical technology company: Despite the Covid-19 turbulent times, uncertainty and unknown entrepreneurial risks, stimOS was able to acquire substantial funding to allow further company expansion. The investment will be used to turn the patented "Mimicking Bone Technology (MBT)" into an internationally indust
 
5. March 2020

MedTech Radar LIVE 2020: Focus on digital therapies

How can digital therapies change healthcare? Which potentials exist in the fields of cardiology, diabetology and endoprosthetics? How can established companies and start-ups in the medtech sector adapt to the new healthcare and business models? These questions and more will be discussed together with experts from the medtech sector during the MedTech Radar LIVE 2020 on June 9th in Cologne. Start-ups active in one of those fields are invited to apply for the start-up pitches. A preview of the
 
15. January 2020
Biograil secures seed funding for oral delivery device with potential to transform market for injectables
Biograil ApS, an innovative biotechnology company developing a unique oral device for delivery of biologics that would otherwise be injected, today announced the closing of a seed funding of 3 Million Euro (with potential to expand to 5 Million Euro). The investor Syndicate was led by the experienced German seed investor High-Tech Gründerfonds (HTGF) and included Danish Megatrend Invest a/s, Swiss Investment group as well as a Danish private healthcare investor. The device is being developed a
 

Events

2. March 2021
MedTech Pitch Day 2021
You are a founder in the field of medical technology and would like to present your company to investors and corporates? Or you would like to present your innovation in the field of Digital Health/AI to a curious audience? Then you have come to the right place! On 02.03.2021 the MedTech Pitch Day will take place online. An event by investors and corporates for founders! Initiators and hosts are the B. Braun Foundation, Dräger, the Techniker Krankenkasse, the Philips Health Innovation Port (HIP)
 
8. June 2021
Pitch & Pinot: Age Tech
 “Pitch & Pinot” powered by Get Started, High Tech Gründerfonds, Q Hub & The Senovation Award! Focus: AgeTech Date: 08.06.2021 Time: 18:00 to 20:15 The chance for startups to meet ten investors and three delicious wines in a casual atmosphere. Each startup will have three minutes for their pitch, followed by one minute Q&A by the investors. HTGF participant in the jury: Dr. Anke Caßing (Principal/Authorized representative). Link to the event can be found here. Deadline
 
18. October 2021
Deep Startup Ecosystem Conference
Deep Startup Ecosystem Conference is a 1-day conference with up to 100 ecosystem leaders, investors, companies and governments. Date: October 8th, 2021 Location: Essen, Germany Dr. Anke Caßing, Principal at HTGF, as a key-note speaker, will be sharing her extensive experience on “16 years of HTGF: Learnings from shaping the German DEEP Tech Ecosystem by bringing together public and private investors“. Link to the event can be found here.